ATC code None PubChem CID 45381907 Formula C16H19N5O4S Molar mass 377.418 g/mol | CAS Number 912574-69-7 ChemSpider 32698379 3D model (Jmol) Interactive image | |
 | ||
Selurampanel (INN, code name BGG492) is a drug closely related to the quinoxalinedione series which acts as a competitive antagonist of the AMPA and kainate receptors and, as of 2015, is being investigated in clinical trials by Novartis for the treatment of epilepsy. It has also been studied in the acute treatment of migraine, and was found to produce some pain relief, but with a relatively high rate of side effects.
References
Selurampanel Wikipedia(Text) CC BY-SA